Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02151045
Other study ID # 8708
Secondary ID
Status Recruiting
Phase Phase 3
First received May 28, 2014
Last updated August 31, 2015
Start date March 2012
Est. completion date March 2017

Study information

Verified date August 2015
Source University Hospital, Montpellier
Contact Eric ET THOMAS, MD
Phone +33 4 67 33 86 40
Email e-thomas@chu-montpellier.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.


Recruitment information / eligibility

Status Recruiting
Enrollment 112
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Informed consent

- Aged from 18 to 65 years

- Affiliated or benefit from an insurance regimen

- Patient with a sciatic answering to the definition

- Discal sciatica more than 15 days and less than 6 months

- Discal hernia (scan or RMI)

- Negative BHCG and normal coagulation parameters

Exclusion Criteria:

- History of lumbar surgery

- Spinal infiltration of corticoids in 30 days before inclusion

- Iode allergy

- Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA

- Motor loss < 4 (muscular testing)

- Sphincter disorder (cauda equida syndrome)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Non target epidural infiltration done at L3-L4 stage
For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control
Epidural infiltration on contact of disco radicular conflict
For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.

Locations

Country Name City State
France CHU de Montpellier - Hôpital Lapeyronie Montpellier
France CHU Carémeau Nîmes

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain evolution on analogic visual scale (EVA) ay Day 30 at Day 30 after infiltration No
Secondary Pain evolution on analogic visual scal (EVA) at Day 7 at day 7 after infiltration No
Secondary Pain evolution on analogic visual scal (EVA) at month 3 at month 3 after infiltration No
Secondary Pain evolution on analogic visual scal (EVA) at month 6 at month 6 after infiltration No
Secondary Pain evolution on analogic visual scal (EVA) at month 12 at month 12 after infiltration No
Secondary drug consumption at day 7 at day 7 after infiltration No
Secondary drug consumption at month 3 at month 3 after infiltration No
Secondary drug consumption at month 6 at month 6 after infiltration No
Secondary drug consumption at month 12 at month 12 after infiltration No
Secondary functional handicap at Day 7 functional handicap is assessed by auto-questionnary at day 7 after infiltration No
Secondary functional handicap at month 3 functional handicap is assessed by auto-questionnary at month 3 after infiltration No
Secondary functional handicap at month 6 functional handicap is assessed by auto-questionnary at month 6 after infiltration No
Secondary functional handicap at month 12 functional handicap is assessed by auto-questionnary at month 12 after infiltration No
Secondary professional activity recovery at Day 7 professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? at day 7 after infiltration No
Secondary professional activity recovery at month 3 professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? at month 3 after infiltration No
Secondary professional activity recovery at month 6 professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? at month 6 after infiltration No
Secondary professional activity recovery at month 12 professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? at month 12 after infiltration No
Secondary new epidural infiltration or surgery of discal hernia at Day 7 at day 7 after infiltration No
Secondary new epidural infiltration or surgery of discal hernia at month 3 at month 3 after infiltration No
Secondary new epidural infiltration or surgery of discal hernia at month 6 at month 6 after infiltration No
Secondary new epidural infiltration or surgery of discal hernia at month 12 at month 12 after infiltration No
See also
  Status Clinical Trial Phase
Terminated NCT01482897 - Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica Phase 3